Expressed hypervariable polymorphism of apolipoprotein (a).
about
Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjectsEffect of Nandrolone Decanoate on serum lipoprotein (a) and its isoforms in hemodialysis patientsCharacterization by yeast artificial chromosome cloning of the linked apolipoprotein(a) and plasminogen genes and identification of the apolipoprotein(a) 5' flanking region.Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities.Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus.1992 American Society of Human Genetics presidential address: back to the future.Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes.Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a)Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus.Lipoprotein(a): an elusive cardiovascular risk factorA pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians.The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.LP(a) phenotypes and levels in angiographically proven coronary heart disease patients and controlsThe roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab.
P2860
Q24792333-E54D693B-1FC6-43B1-867C-8EF1A494784DQ24803599-BD1381D7-6C7E-454F-BFCA-558B2A038652Q31009837-B3804DB2-2016-4A86-925B-8E555C368318Q33888645-471BCD97-74D5-4DD2-8A06-172A5308C3D7Q33905292-C1DD22B6-30A5-469B-880A-8A1CE01C3F73Q34151817-E74791AD-F8B9-4925-A259-D108B4636A89Q35194570-3956E192-7424-40C2-AFBC-8A8059E5AA59Q35195920-1E7586F5-E791-466D-BE38-345BCFC3D63CQ35608863-0C4D6B5C-DBD3-476B-8FBF-064E772456C7Q35643684-EBC98327-7CB1-40BA-965D-B19E534E8413Q35746190-2657AFE1-F2AE-4D72-A2F0-92FE4B6387F4Q35750052-709EFBB9-D65E-4707-8939-5F39488D9119Q35824543-700A6539-1D80-4013-9C39-375E685766C9Q36515765-BE92253B-0AA3-471E-B809-B09CF81A17C1Q36536773-59CF2BE5-D672-4456-9A05-F18F5BB7A3BFQ40335473-E50A4C5F-AE91-4F8E-AC94-5A52EE470F43Q41808457-1F9DB2E2-4343-4969-BA96-BE2DCCBC0FA9Q46857725-B37E8871-3858-4B75-9E29-0E201BF65715
P2860
Expressed hypervariable polymorphism of apolipoprotein (a).
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Expressed hypervariable polymorphism of apolipoprotein (a).
@ast
Expressed hypervariable polymorphism of apolipoprotein (a).
@en
type
label
Expressed hypervariable polymorphism of apolipoprotein (a).
@ast
Expressed hypervariable polymorphism of apolipoprotein (a).
@en
prefLabel
Expressed hypervariable polymorphism of apolipoprotein (a).
@ast
Expressed hypervariable polymorphism of apolipoprotein (a).
@en
P2093
P2860
P1476
Expressed hypervariable polymorphism of apolipoprotein (a).
@en
P2093
B A Kottke
M I Kamboh
R E Ferrell
P2860
P304
P407
P577
1991-11-01T00:00:00Z